Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation

Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation

Glioblastoma multiforme (GBM) is the most frequent and most aggressive brain tumor in adults. The dismal prognosis is due to postsurgery recurrences arising from escaped invasive tumor cells. The signaling pathways activated in invasive cells are under investigation, and models are currently designe...

Descripció completa

Dades bibliogràfiques
Autors principals:	Jennifer R. Molina, Yuho Hayashi, Clifton Stephens, Maria-Magdalena Georgescu
Format:	Article
Idioma:	English
Publicat:	Elsevier 2010-06-01
Col·lecció:	Neoplasia: An International Journal for Oncology Research
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S147655861080003X

Ítems similars

FDFT1 maintains glioblastoma stem cells through activation of the Akt pathway
per: Hui Mo, et al.
Publicat: (2024-12-01)

PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT
per: Carmen Mecca, et al.
Publicat: (2018-04-01)

Glycation Leads to Increased Invasion of Glioblastoma Cells
per: Paola Schildhauer, et al.
Publicat: (2023-04-01)

NHERF1/EBP50 Is a New Marker in Colorectal Cancer
per: Yuho Hayashi, et al.
Publicat: (2010-12-01)

Prion protein regulates invasiveness in glioblastoma stem cells
per: Mariana B. Prado, et al.
Publicat: (2024-12-01)

Astrocytes enhance the invasion potential of glioblastoma stem-like cells.
per: Barbara H Rath, et al.
Publicat: (2013-01-01)

Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
per: Waldman Todd, et al.
Publicat: (2009-10-01)

Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential
per: Dimitra Manou, et al.
Publicat: (2020-05-01)

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
per: Andrej Porčnik, et al.
Publicat: (2021-08-01)

Small cell glioblastoma: A glioblastoma subtype with an unexpected response
per: Ionela Bizu, et al.
Publicat: (2019-06-01)

The Glycoprotein M6a Is Associated with Invasiveness and Radioresistance of Glioblastoma Stem Cells
per: Marie Geraldine Lacore, et al.
Publicat: (2022-07-01)

Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model.
per: Stine Skov Jensen, et al.
Publicat: (2016-01-01)

Induction of Akt Activity by Chemotherapy Confers Acquired Resistance
per: Wei-Chien Huang, et al.
Publicat: (2009-03-01)

Towards Clinical AKT Inhibition in Glioblastoma
per: Hanah Gull, et al.
Publicat: (2023-01-01)

Absence of AKT1 mutations in glioblastoma.
per: Fonnet E Bleeker, et al.
Publicat: (2009-05-01)

Activated T cell therapy targeting glioblastoma cancer stem cells
per: Ken Miyaguchi, et al.
Publicat: (2023-01-01)

Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells
per: Ivan Trus, et al.
Publicat: (2020-05-01)

Neuropilin-1 modulates the 3D invasive properties of glioblastoma stem-like cells
per: Mathilde Kerhervé, et al.
Publicat: (2022-09-01)

EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
per: Benjamin Krusche, et al.
Publicat: (2016-06-01)

Mechanism of acquired temozolomide resistance in glioblastoma
per: McFaline-Figueroa, José L
Publicat: (2014)

Glioblastoma Multiforme Stem Cells
per: Irena Dimov, et al.
Publicat: (2011-01-01)

MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
per: Xu Zhang, et al.
Publicat: (2021-01-01)

NHERF-1: Modulator of Glioblastoma Cell Migration and Invasion
per: Kerri L. Kislin, et al.
Publicat: (2009-04-01)

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
per: Rasime Kalkan
Publicat: (2015-11-01)

Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue.
per: Marco Wallenborn, et al.
Publicat: (2020-01-01)

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
per: Rasime Kalkan
Publicat: (2015-01-01)

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
per: Kirstine Jacobsen, et al.
Publicat: (2017-09-01)

Monocarboxylate transporter dependent mechanism is involved in proliferation, migration, and invasion of human glioblastoma cell lines via activation of PI3K/Akt signaling pathway.
per: Chen Gao, et al.
Publicat: (2024-01-01)

Adipose Tissue-Derived Stem Cell Extracellular Vesicles Suppress Glioblastoma Proliferation, Invasiveness and Angiogenesis
per: Dovydas Gečys, et al.
Publicat: (2023-04-01)

Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells
per: Dongfeng Han, et al.
Publicat: (2019-07-01)

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
per: Xu Zhang, et al.
Publicat: (2022-04-01)

Insulin receptor substrate 1 overexpression promotes survival of glioblastoma cells through AKT1 activation
per: Gokhan Gorgisen, et al.
Publicat: (2020-03-01)

Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.
per: Peter C Huszthy, et al.
Publicat: (2015-01-01)

Investigating acquired temozolomide resistance in adult glioblastoma
per: Wong, ZY
Publicat: (2020)

Tumor Stem Cells in Glioblastoma Multiforme
per: Mahbobeh Farokhpour
Publicat: (2012-06-01)

Cancer Stem Cells in Glioblastoma Multiforme
per: Amy Ruth Bradshaw, et al.
Publicat: (2016-08-01)

Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival
per: Paul Guilhamon, et al.
Publicat: (2021-01-01)

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
per: Yong Zheng, et al.
Publicat: (2021-03-01)

The small GTPase RhoG mediates glioblastoma cell invasion
per: Kwiatkowska Aneta, et al.
Publicat: (2012-09-01)

Downregulation of Williams syndrome transcription factor (WSTF) suppresses glioblastoma cell growth and invasion by inhibiting PI3K/AKT signal pathway
per: Liyuan Yang, et al.
Publicat: (2021-11-01)